Table 7 Mean difference of performance status scores
(A) | (B) | Â | Mean difference (A-B) | SE | 95% Confidence interval of difference | P-value | |
|---|---|---|---|---|---|---|---|
Lower | Upper | ||||||
Baseline (ECOG) | End of 2nd week (ECOG) | Placebo | 0 | 0 | 0 | 0 | 0 |
Bupropion | 0.15 | 0.1 | - 0.07 | 0.38 | 0.16 | ||
End of 6th week (ECOG) | Placebo | 0.14 | 0.09 | - 0.06 | 0.3 | 0.16 | |
Bupropion | 0.8 | 0.1 | 0.6 | 1.07 | 0.001> | ||
End of 2nd week (ECOG) | End of 6th week (ECOG) | Placebo | 0.14 | 0.09 | - 0.067 | 0.3 | 0.16 |
Bupropion | 0.7 | 0.13 | 0.4 | 0.98 | 0.001> | ||
Baseline (Karnofsky) | End of 2nd week (Karnofsky) | Placebo | 0 | 0 | 0 | 0 | – |
Bupropion | - 2.3 | 1.2 | - 4.9 | 0.3 | 0.08 | ||
End of 6th week (Karnofsky) | Placebo | - 2.8 | 1.6 | - 6.38 | 0.67 | 0.1 | |
Bupropion | - 12.3 | 1.2 | - 14.9 | - 9.6 | 0.001> | ||
End of 2nd week (Karnofsky) | End of 6th week (Karnofsky) | Placebo | - 2.8 | 1.6 | - 6.38 | 0.67 | 0.1 |
Bupropion | - 10 | 1.1 | - 12.4 | - 7.5 | 0.001> | ||